Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and α-synuclein pathology

被引:47
作者
Newman, J
Rissman, RA
Sarsoza, F
Kim, RC
Dick, M
Bennett, DA
Cotman, CW
Rohn, TT
Head, E
机构
[1] Univ Calif Irvine, Dept Neurol, Inst Brain Aging & Dementia, Irvine, CA 92697 USA
[2] Boise State Univ, Dept Biol, Boise, ID 83725 USA
[3] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
caspase activation; Pick's disease; progressive supranuclear palsy; corticobasal degeneration; frontotemporal dementia;
D O I
10.1007/s00401-005-1027-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and dementia with Lewy bodies (DLB) are diseases associated with the accumulation of tau or alpha-synuclein. In AD, beta-amyloid (A beta)-associated caspase activation and cleavage of tau at Asp(421) (Delta Tau) may be an early step in neurofibrillary tangle (NFT) formation. To examine whether Delta Tau accumulates in other diseases not characterized by extracellular A beta accumulation, we examined PiD, PSP, and CBD cases in comparison to those without extensive tau accumulation including frontotemporal lobar degeneration without Pick bodies (FTLD) and control cases. Additionally, we studied Delta Tau accumulation in DLB cases associated with intracellular alpha-synuclein. Delta Tau was observed in all disease cases except non-PiD FTLD and controls. These results demonstrate that the accumulation of Delta Tau may represent a common pathway associated with abnormal accumulation of intracellular tau or alpha-synuclein and may be relatively less dependent on the extracellular accumulation of A beta in non-AD dementias.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 55 条
[1]   Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration [J].
Arai, T ;
Ikeda, K ;
Akiyama, H ;
Nonaka, T ;
Hasegawa, M ;
Ishiguro, K ;
Iritani, S ;
Tsuchiya, K ;
Iseki, E ;
Yagishita, S ;
Oda, T ;
Mochizuki, A .
ANNALS OF NEUROLOGY, 2004, 55 (01) :72-79
[2]  
Baba M, 1998, AM J PATHOL, V152, P879
[3]   PHOSPHORYLATION OF SER(262) STRONGLY REDUCES BINDING OF TAU-PROTEIN TO MICROTUBULES - DISTINCTION BETWEEN PHF-LIKE IMMUNOREACTIVITY AND MICROTUBULE-BINDING [J].
BIERNAT, J ;
GUSTKE, N ;
DREWES, G ;
MANDELKOW, EM ;
MANDELKOW, E .
NEURON, 1993, 11 (01) :153-163
[4]   STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
BRAAK, H ;
BRAAK, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278
[5]   ABNORMAL TAU-PHOSPHORYLATION AT SER(396) IN ALZHEIMERS-DISEASE RECAPITULATES DEVELOPMENT AND CONTRIBUTES TO REDUCED MICROTUBULE-BINDING [J].
BRAMBLETT, GT ;
GOEDERT, M ;
JAKES, R ;
MERRICK, SE ;
TROJANOWSKI, JQ ;
LEE, VMY .
NEURON, 1993, 10 (06) :1089-1099
[6]   EVIDENCE FOR OXIDATIVE STRESS IN PICK DISEASE AND CORTICOBASAL DEGENERATION [J].
CASTELLANI, R ;
SMITH, MA ;
RICHEY, PL ;
KALARIA, R ;
GAMBETTI, P ;
PERRY, G .
BRAIN RESEARCH, 1995, 696 (1-2) :268-271
[7]   Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease [J].
Castellani, R ;
Smith, MA ;
Richey, PL ;
Perry, G .
BRAIN RESEARCH, 1996, 737 (1-2) :195-200
[8]  
Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO
[9]  
2-E
[10]  
FEANY MB, 1995, AM J PATHOL, V146, P1388